In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Andrés Baeza-MoralesImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-3270-307X Sandra Pascual-GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0002-0536-1185 Pascual Martínez-PeinadoImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-4370-5468 Alicia Navarro-SempereImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.
Yolanda SegoviaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-1727-2603 Miguel Medina-GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0009-0006-1924-8729 Carolina Pujalte-SatorreImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.
Rúben Rodriguesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0009-0007-5491-0770 Magdalena GarcíaImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0002-6823-4781 Rosa María Martínez-EspinosaBiochemistry and Molecular Biology and Edaphology and Agricultural Chemistry Department, Faculty of Sciences, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0003-2679-135X M Helena Vasconcelosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-7801-4643 José Miguel Sempere-OrtellsImmunology, Cellular and Developmental Biology Group, Department of Biotechnology, University of Alicante, Ap. 99, E-03080 Alicante, Spain.ORCID 0000-0001-5439-0604 Funding
Generalitat Valenciana PROMETEO/2021/055Ministry of Science, Innovation and Universities FPU21/02299
6 · The paper itselfAbstract
Bacterioruberin (BR), a C
Indexed as
Antineoplastic AgentsCarotenoidsHaloferax mediterraneiA549 CellsApoptosisCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmDrug Screening Assays, AntitumorHumansLung NeoplasmsAntineoplastic AgentsbacterioruberinCarotenoidsapoptosisbacterioruberinHaloferax mediterraneimultidrug resistanceoxidative stressP-glycoprotein
Identifiers
PMID42589317
PMCPMC13467541
What Socratic holds
Textmetadata
Read underepoch 390